Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: Survey of health professionals

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Kalilani Phiri, Linda V ^a   Lungu, Douglas ^b   Coghlan, Renia ^c  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Daeyang Luke Hospital   (Malawi)

^c Medicines for Malaria Venture   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE;

ABDOMINAL PAIN; ADULT; ANEMIA; ANOREXIA; ARTICLE; CLINICAL DECISION MAKING; DIARRHEA; DIZZINESS; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG SURVEILLANCE PROGRAM; FATIGUE; FEMALE; FETOTOXICITY; HALLUCINATION; HEALTH SURVEY; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; INDIGESTION; JAUNDICE; LETHARGY; LIVER TOXICITY; MALARIA; MALAWI; MALE; MOUTH PAIN; NAUSEA; NEPHROTOXICITY; PATIENT COMPLIANCE; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; RASH; SLEEP DISORDER; VOMITING; CROSS-SECTIONAL STUDY; DRUG COMBINATION; HEALTH PERSONNEL ATTITUDE; METHODOLOGY; PHARMACIST; PHYSICIAN; PROFESSIONAL COMPETENCE; QUESTIONNAIRE; STATISTICS;

ADULT; ANTIMALARIALS; ARTEMISININS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALARIA; MALAWI; MALE; PHARMACISTS; PHYSICIANS; PROFESSIONAL COMPETENCE; QUESTIONNAIRES;

EID: 80053173475     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-279     Document Type: Article

References (17)

1. World Malaria Report 2009, World Health Organization. 2010 http://www.who.int/malaria/world-malaria-report-2009/en/index.html
2. Insecticide-treated bed nets and curtains for preventing malaria. Lengeler C, Cochrane Database Syst Rev 2004 2 D000363 15106149
3. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG, Malar J 2008 11 7 Suppl 1 7
4. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrade-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, J Infect Dis 1997 176 1590 1596 10.1086/514159 9395372 (Pubitemid 27518161)
5. Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy! Mutabingwa TK, Acta Tropica 2005 95 305 315 10.1016/j.actatropica.2005.06.009 16098946 (Pubitemid 41207297)
6. Combination therapy formalaria in Africa: hype or hope? Bloland PB, Ettling M, Meek S, Bull World Health Org 2000 78 1378 1388 11196485 (Pubitemid 32105022)
7. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Mubyazi GM, Gonzalez-Block MA, Malar J 2005 20 51
8. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS, Malekela DA, East Afr J Public Health 2007 4 43 6 17907761
9. Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation. Minzi OM, Haule AF, East Afr J Public Health 2008 5 117 21 19024421
10. Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. Kurth F, Bélard S, Adegnika AA, Gaye O, Kremsner PG, Ramharter M, Lancet Infect Dis 2010 10 125 32 10.1016/S1473-3099(09)70327-5 20113981
11. Impact of the national protocol for malaria treatment on prescribing patterns in Gezira state, Sudan. Ahmed ME, Youssif MA, East Mediterr Health J 2004 10 566 572 16335648 (Pubitemid 41723441)
12. Diagnosis and prescribing practices in peripheral health facilities in rural western Kenya. Phillips-Howard PA, Wannemuehler KA, Ter Kuile FO, Hawley WA, Kolczak MS, Odhacha A, Vulule JM, Nahlen BL, Am J Trop Med Hyg 2003 68 44 49 12749485 (Pubitemid 38240681)
13. Treat-ment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon. Sayang C, Gausseres M, Vernazza-Licht N, Malvy D, Bley D, Millet P, Malar J 2009 29 176
14. Treat-ment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon. Sayang C, Gausseres M, Vernazza-Licht N, Malvy D, Bley D, Millet P, Malar J 2009 29 174
15. The sick placenta-the role of malaria. Brabin BJ, Romagosa C, Abdelgalil S, Menéndez C, Verhoeff FH, McGready R, Fletcher KA, Owens S, D'Alessandro U, Nosten F, Fischer PR, Ordi J, Placenta 2004 25 359 78 10.1016/j.placenta.2003.10.019 15081631 (Pubitemid 38519110)
16. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Alker AP, Kwiek JJ, Meshnick SR, PLoS One 2007 2 11 1166. 18000538
17. Malaria misdiagnosis: effects on the poor and vulnerable. Amexo M, Tolhurst R, Barnish G, Bates I, The Lancet 2004 364 1896 1898 10.1016/S0140-6736(04)17446-1 (Pubitemid 39536094)